Acequia Capital Origin 21 Lp investment portfolio

Apoha Limited develops AI‑driven sensory‑intelligence platforms that model and predict molecular behaviour, offering tools for biotechnology research and development. Its products target scientists and organisations working on molecular science and related biotech applications.

ExpressionEdits provides an AI‑driven platform that integrates short intron sequences into synthetic genes to enhance gene expression and increase protein yields for therapeutic and research applications. Its services are aimed at biotechnology and pharmaceutical companies requiring high‑output protein production.